FDA Import Refusal B4S-0008135-4/11/3 — Biocon Biologics Limited
The FDA refused shipment B4S-0008135-4/11/3 from Biocon Biologics Limited (India) on June 10, 2022. The refused product falls under Drugs and Biologics — SIROLIMUS (IMMUNOSUPPRESSIVE). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 10, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64TCS12 SIROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 118